Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction
Ana Andres‐Hernando, David J. Orlicky, Masanari Kuwabara, et al.
Cell Metabolism (2020) Vol. 32, Iss. 1, pp. 117-127.e3
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases
Vasanti Malik, Frank B. Hu
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 4, pp. 205-218
Open Access | Times Cited: 508
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson, Brian N. Finck
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 484-495
Open Access | Times Cited: 334
Molecular aspects of fructose metabolism and metabolic disease
Mark A. Herman, Morris J. Birnbaum
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2329-2354
Open Access | Times Cited: 192
Metabolic drivers of non-alcoholic fatty liver disease
Kendra K. Bence, Morris J. Birnbaum
Molecular Metabolism (2020) Vol. 50, pp. 101143-101143
Open Access | Times Cited: 154
Fructose and the Liver
Pablo Muriel, Pedro López‐Sánchez, Erika Ramos‐Tovar
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 109
“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
Mark A. Febbraio, Michael Karin
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2316-2328
Open Access | Times Cited: 104
Fructose contributes to the Warburg effect for cancer growth
Takahiko Nakagawa, Miguel A. Lanaspa, Íñigo San Millán, et al.
Cancer & Metabolism (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 110
Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol
James M. Eng, Jennifer L. Estall
Cells (2021) Vol. 10, Iss. 7, pp. 1805-1805
Open Access | Times Cited: 98
Recent advances in fructose intake and risk of hyperuricemia
Congwang Zhang, Lijun Li, Yipeng Zhang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110795-110795
Open Access | Times Cited: 95
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction
Jemy A. Gutierrez, Wei Liu, Sylvie Perez, et al.
Molecular Metabolism (2021) Vol. 48, pp. 101196-101196
Open Access | Times Cited: 65
Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation
Ana Andres‐Hernando, Christina Cicerchi, Masanari Kuwabara, et al.
Nature Metabolism (2021) Vol. 3, Iss. 9, pp. 1189-1201
Open Access | Times Cited: 60
Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD
Mustafa Kutlu Inci, Sehyung Park, Robert N. Helsley, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 114, pp. 109224-109224
Open Access | Times Cited: 39
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
Gideon G. Kang, Natalie L. Trevaskis, Andrew Murphy, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105905-105905
Open Access | Times Cited: 38
The fructose survival hypothesis for obesity
Richard J. Johnson, Miguel A. Lanaspa, Laura G. Sánchez‐Lozada, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1885
Open Access | Times Cited: 27
The pathophysiology of MASLD: an immunometabolic perspective
Julian Schwärzler, Felix Grabherr, Christoph Grander, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 375-386
Closed Access | Times Cited: 27
Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach
Tilal Elsaman, Magdi Awadalla Mohamed
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 126-126
Open Access | Times Cited: 1
High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells
Sangmoo Jeong, Angela Maria Savino, Rachel Chirayil, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 145-159.e6
Open Access | Times Cited: 54
Tissue-Specific Fructose Metabolism in Obesity and Diabetes
Robert N. Helsley, F. Moreau, Manoj K. Gupta, et al.
Current Diabetes Reports (2020) Vol. 20, Iss. 11
Open Access | Times Cited: 51
The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
Siyu Yu, Chunlin Li, Guang Ji, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis
Liangyou Rui, Jiandie D. Lin
Annual Review of Nutrition (2022) Vol. 42, Iss. 1, pp. 91-113
Open Access | Times Cited: 34
Metabolism and Health Impacts of Dietary Sugars
Yasmine Alam, Raymond Kim, Cholsoon Jang
Journal of Lipid and Atherosclerosis (2022) Vol. 11, Iss. 1, pp. 20-20
Open Access | Times Cited: 30
Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD
Sehyung Park, Robert N. Helsley, Taghreed Fadhul, et al.
Metabolism (2023) Vol. 145, pp. 155591-155591
Open Access | Times Cited: 19
The Role of Uric Acid in Human Health: Insights from the Uricase Gene
Youssef M. Roman
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1409-1409
Open Access | Times Cited: 19
Could Alzheimer’s disease be a maladaptation of an evolutionary survival pathway mediated by intracerebral fructose and uric acid metabolism?
Richard J. Johnson, Dean R. Tolan, Dale E. Bredesen, et al.
American Journal of Clinical Nutrition (2023) Vol. 117, Iss. 3, pp. 455-466
Open Access | Times Cited: 18
Drug development advances in human genetics‐based targets
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top